Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
MDxHealth | MDXH | Nov 22, 2024 | 1.88 | +9.94 |
Medalist Diversified REIT | MDRR | Nov 22, 2024 | 12.22 | -1.45 |
Medalist Diversified REIT A Pref | MDRRP | Nov 22, 2024 | 25.30 | -2.32 |
Medallion Bank F Pref | MBNKP | Nov 22, 2024 | 25.70 | -2.51 |
Medallion Financial | MFIN | Nov 22, 2024 | 9.56 | -0.10 |
MediaAlpha | MAX | Nov 22, 2024 | 12.73 | -0.16 |
Mediaco A | MDIA | Nov 22, 2024 | 1.32 | +3.94 |
Medical Properties Trust | MPW | Nov 22, 2024 | 4.31 | +1.65 |
MediciNova | MNOV | Nov 22, 2024 | 2.13 | +6.50 |
Medicus Pharma | MDCX | Nov 22, 2024 | 1.92 | 0.00 |
Medifast | MED | Nov 22, 2024 | 18.41 | +0.60 |
MEDIROM Healthcare Technologies ADR | MRM | Nov 22, 2024 | 2.71 | -6.02 |
MediWound | MDWD | Nov 22, 2024 | 16.48 | -1.67 |
Mednax | MD | Nov 22, 2024 | 14.96 | +1.42 |
Medpace | MEDP | Nov 22, 2024 | 337.75 | -1.19 |
Medtronic | MDT | Nov 22, 2024 | 86.21 | +1.73 |
Mega Matrix | MPU | Nov 22, 2024 | 1.67 | +2.45 |
Megacap 300 Growth Index ETF Vanguard | MGK | Nov 22, 2024 | 335.89 | +0.01 |
Megacap 300 Index ETF Vanguard | MGC | Nov 22, 2024 | 214.00 | +0.25 |
Megacap 300 Value Index ETF Vanguard | MGV | Nov 22, 2024 | 132.26 | +0.77 |
MEI Pharma | MEIP | Nov 22, 2024 | 2.78 | -1.07 |
Meihua International Medical Technologies | MHUA | Nov 22, 2024 | 0.72 | +4.73 |
MeiraGTx Holdings | MGTX | Nov 22, 2024 | 5.93 | +0.17 |
Meiwu Technology | WNW | Nov 22, 2024 | 0.84 | +0.66 |
Melar Acquisition I | MACIU | Nov 22, 2024 | 10.14 | 0.00 |
Melar Acquisition I | MACI | Nov 22, 2024 | 10.03 | -0.16 |
Melco Resorts & Entertainment ADR | MLCO | Nov 22, 2024 | 5.95 | -1.82 |
MercadoLibre | MELI | Nov 22, 2024 | 2 005.00 | +1.87 |
Mercantile Bank | MBWM | Nov 22, 2024 | 50.39 | +2.75 |
Mercer International | MERC | Nov 22, 2024 | 6.40 | +0.63 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.